NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268958. A total of 5 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -99.9% | 100 | -99.8% | 0.00% | – |
| Q4 2021 | $727,000 | -4.3% | 53,800 | +27.2% | 0.00% | – |
| Q3 2021 | $760,000 | +4.7% | 42,300 | 0.0% | 0.00% | – |
| Q2 2021 | $726,000 | -14.2% | 42,300 | 0.0% | 0.00% | – |
| Q1 2021 | $846,000 | +147.4% | 42,300 | +125.0% | 0.00% | – |
| Q3 2019 | $342,000 | -47.5% | 18,800 | 0.0% | 0.00% | – |
| Q2 2019 | $652,000 | -61.0% | 18,800 | -62.2% | 0.00% | – |
| Q1 2019 | $1,673,000 | +27.2% | 49,800 | +24.5% | 0.00% | – |
| Q4 2018 | $1,315,000 | -98.1% | 40,000 | -97.2% | 0.00% | -100.0% |
| Q2 2018 | $68,880,000 | +1923.5% | 1,410,600 | +2374.7% | 0.01% | +1300.0% |
| Q4 2017 | $3,404,000 | – | 57,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 4,685 | $28,560,000 | 3.66% |
| BOOTHBAY FUND MANAGEMENT, LLC | 158 | $963,000 | 0.10% |
| GROUP ONE TRADING, L.P. | 140,900 | $8,589,000 | 0.07% |
| SIMPLEX TRADING, LLC | 667 | $4,066,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |